ENVERIC BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.0M | $-1.6M | $-2.2M | $-1.9M | $-2.5M | $-2.2M | $-3.2M | $-2.1M |
| Depreciation & Amortization | $36.8K | $37.2K | $39.5K | $40.4K | $40.0K | $81.0K | $82.5K | $84.8K |
| Depreciation | $36.8K | $37.2K | $39.5K | $40.4K | $40.0K | $38.8K | $40.3K | $42.6K |
| Amortization | — | — | $2 | $0 | $-2 | $42.2K | $42.2K | $42.2K |
| Stock-Based Compensation | $125.1K | $88.7K | $240.2K | $187.0K | $206.3K | $193.8K | $471.7K | $369.6K |
| Net Cash from Operating Activities | $-2.4M | $-2.3M | $-1.8M | $-2.1M | $-1.9M | $-2.4M | $-1.3M | $-927.1K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $5.8M | $2.5M | $2.7M | $3.0M | $449.1K | $4.4M | $463.4K | $517.7K |
| Net Change in Cash | $3.4M | $231.3K | $919.9K | $907.8K | $-1.4M | $2.1M | $-870.7K | $-390.9K |
| Free Cash Flow | — | — | — | — | — | — | — | — |